Foresite Capital Fund III is a Venture Capital Fund in California with $283.12 mm assets under management. It has 163 beneficial owners. Data from SEC filing.
Company profile
Employees
Incorporated
Location
Fiscal year end
Industry
SEC CIK
AUM ?
$283.12 mm
Address
Foresite Capital Fund III
600 MONTGOMERY STREET
SUITE 4500
SAN FRANCISCO
CA 94111
600 MONTGOMERY STREET
SUITE 4500
SAN FRANCISCO
CA 94111
Phone
415-877-4887
Ownership
Fund structure | AUM | Fund type |
---|---|---|
Foresite Capital | $3.91 bn | |
Foresite Capital Fund I, LP | $128.99 mm | Venture Capital Fund |
Foresite Capital Fund II, LP | $308.54 mm | Venture Capital Fund |
Foresite Capital Fund III, LP | $283.12 mm | Venture Capital Fund |
Foresite Capital Fund IV, LP | $1.60 bn | Venture Capital Fund |
Foresite Capital Fund V, L.P. | $1.08 bn | Venture Capital Fund |
Foresite Capital Fund VI LP | Venture Capital Fund | |
Foresite Capital Fund VI (Feeder), LP | ||
Foresite Capital Opportunity Fund V, L.P. | $316.10 mm | Venture Capital Fund |
Foresite Capital Vi-a, LLC | $18.12 mm | Venture Capital Fund |
Foresite Labs Fund I, L.P. | $167.52 mm | Venture Capital Fund |
Latest filings (excl ownership)
Latest ownership filings
SC 13G/A
Aclaris Therapeutics, Inc.
11 Feb 22
4
James B. Tananbaum
3 Nov 21
SC 13G/A
CymaBay Therapeutics, Inc.
16 Feb 21
SC 13G/A
Aclaris Therapeutics, Inc.
11 Feb 21
3
James B. Tananbaum
10 Feb 21
SC 13G
Aclaris Therapeutics, Inc.
27 Oct 20
4
James B. Tananbaum
2 Mar 20
SC 13G/A
Replimune Group, Inc.
14 Feb 20
SC 13G/A
CymaBay Therapeutics, Inc.
14 Feb 20
3/A
James B. Tananbaum
5 Nov 19